TissueScan, Prostate Cancer cDNA Array III

CAT#: HPRT103

48 samples covering 9-normal, 18-Stage II, 19-III, 2-IV. Available in 2, 5, 10 identical plates.

USD 850.00

Availability*
In Stock
Size
    • 2 Panels

Product images

Related Products (2)

HK200550

qPCR primer pairs and template standards against Homo sapiens gene ACTB

    • 1 kit

USD 295.00

HP204660

qSTAR qPCR primer pairs against Homo sapiens gene ACTB

    • 200 rxns

USD 95.00

Previous
Next

Specifications

Product Data
Array Category Cancer Specific
Clinical Info
Diagnosis Prostate Cancer
Tissue Prostate
Array Name Prostate Cancer cDNA Array III
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (10)

The use of this Tissues has been cited in the following citations:
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis ,Ko, CJ;Lan, SW;Lu, YC;Cheng, TS;Lai, PF;Tsai, CH;Hsu, TW;Lin, HY;Shyu, HY;Wu, SR;Lin, HH;Hsiao, PW;Chen, CH;Huang, HP;Lee, MS;, Oncogene 2017 ,PubMed ID 28368394 [Prostate Cancer]
ZFP91: A Noncanonical NF-?B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer ,Paschke, L;Jopek, K;Szyszka, M;Tyczewska, M;Ziolkowska, A;Rucinski, M;Malendowicz, LK;, Biomed Res Int 2016 ,PubMed ID 27975057 [Prostate Cancer]
ZFP91: A Noncanonical NF-B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer ,Paschke, L;Jopek, K;Szyszka, M;Tyczewska, M;Ziolkowska, A;Rucinski, M;Malendowicz, LK;, BioMed Research International 2016 ,PubMed ID 27975057 [Prostate Cancer]
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer ,Lin, VC;Lu, TL;Yin, HL;Yang, SF;Lee, YC;Liu, CC;Huang, CY;Yu, CC;Chang, TY;Huang, SP;Bao, BY;, Int J Mol Sci 2016 ,PubMed ID 27916838 [Prostate Cancer]
ZFP91: A Noncanonical NF-B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer ,Paschke, L;Jopek, K;Szyszka, M;Tyczewska, M;Ziolkowska, A;Rucinski, M;Malendowicz, LK;, BioMed Research International 2016 ,PubMed ID 27975057 [Prostate Cancer]
ZFP91-a non-canonical NF-B pathway regulator with oncogenic properties is overexpressed in prostate cancer. ,Paschke, L;Jopek, K;Szyszka, M;Tyczewska, M;Ziolkowska, A;Rucinski, M;Malendowicz, LK;, downloads.hindawi.com 2016 ,PubMed ID 27975057 [Prostate Cancer]
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer ,Qin, F;Song, Z;Chang, M;Song, Y;Frierson, H;Li, H;, Cancer Lett. Jun 2016 ,PubMed ID 27322736
Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis ,Hu, X;Garcia, C;Fazli, L;Gleave, M;Vitek, MP;Jansen, M;Christensen, D;Mulholland, DJ;, Sci Rep Nov 2015 ,PubMed ID 26563471 [HPRT103]
WNT5A has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo ,Thiele, S;Göbel, A;Rachner, TD;Fuessel, S;Froehner, M;Muders, MH;Baretton, GB;Bernhardt, R;Jakob, F;Glüer, CC;Bornhäuser, M;Rauner, M;Hofbauer, LC;, J. Bone Miner. Res. Sep 2014 ,PubMed ID 25224731 [HP100041]
FGF-2 Disrupts Mitotic Stability in Prostate Cancer through the Intracellular Trafficking Protein CEP57 ,Rolando Cuevas, Nina Korzeniewski, Yanis Tolstov, Markus Hohenfellner, and Stefan Duensing, Cancer Res., Feb 2013; 73: 1400 - 1410. [Prostate Cancer cDNA Array III]
48 Mouse Clones